HomeONTX • NASDAQ
Follow
Onconova Therapeutics Inc
Previous close
$0.87
Year range
$0.55 - $1.45
Market cap
18.27M USD
Avg Volume
91.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 57.00K | 0.00% |
Operating expense | 5.15M | -9.69% |
Net income | -4.74M | 12.21% |
Net profit margin | -8.31K | 12.21% |
Earnings per share | — | — |
EBITDA | -5.08M | 9.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 25.24M | -40.76% |
Total assets | 27.04M | -38.24% |
Total liabilities | 12.52M | 20.29% |
Total equity | 14.52M | — |
Shares outstanding | 21.00M | — |
Price to book | 1.26 | — |
Return on assets | -44.25% | — |
Return on capital | -76.15% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -4.74M | 12.21% |
Cash from operations | -4.47M | -14.59% |
Cash from investing | -14.00K | — |
Cash from financing | — | — |
Net change in cash | -4.48M | -14.41% |
Free cash flow | -2.87M | -43.70% |
About
Founded
1998
Website
Employees
17